AbbVie Inc (NYSE: ABBV)

DRUGS - Drug Manufacturers - Major
Sector: Health Care

Stock price data as of 11/15/2019

Closing price: 88.63

Support price level:	$73.37
Resistance price level:	N/A
Relative strength index (14-day RSI)	89.7
Beta	1.23

ABBV is one of this month's top performers with a return of 15.9 percent, beating 90 percent of stocks in the S&P-100.
Up 4.0 percent, ABBV is one of this week's biggest gainers.
Volatility is forecast to fall over the next month.
ABBV is above its 200-day moving average, providing a measure of support for long positions.
With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
Price broke above prior resistance level - a short-term bullish signal.

Low	High	Price as % of Range
$62.98	$94.27	84.7%

200 day	50 day	20 day	10 day
$75.60	$76.33	$81.66	$84.92

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
28.4%	22.6%	23.4%	27.7%

There is an estimated 5% probability that the stock price of AbbVie Inc will fall by more than: